Viridian Completes THRIVE-2 Enrollment For VRDN-001 In Chronic TED
25 Jul 2024 //
BUSINESSWIRE
AffyImmune Gets FDA RMAT Designation For AIC100 In Thyroid Cancer
23 Jul 2024 //
BUSINESSWIRE
Entera`s Oral PTH Hypoparathyroidism Candidate EB612 Phase 1 Data
03 Jun 2024 //
GLOBENEWSWIRE
Veracyte`s Afirma GRID Suggests Thyroid Tumor Molecular Testing Prognosis
03 Jun 2024 //
BUSINESSWIRE
FDA Sends Warning Letters to Aurobindo, API Repackers
03 Jul 2019 //
RAPS
Izeen Pharma Inc Receives FDA Warning Letter
03 Jul 2019 //
FDA